Mediclinic International MDC

LON: MDC | ISIN: GB00B8HX8Z88   25/05/2023
501,00 GBX (+0,10%)
(+0,10%)   25/05/2023

25 mei 2023 · Ninety One UK Ltd - Form 8.3 - Mediclinic International Plc · Persbericht

24 mei 2023 · Magnetar Capital Partners LP - Form 8.3 - Mediclinic International Plc · Persbericht

23 mei 2023 · Magnetar Capital Partners LP - Form 8.3 - Mediclinic International Plc · Persbericht

23 mei 2023 · Ninety One UK Ltd - Form 8.3 - Mediclinic International Plc · Persbericht

22 mei 2023 · Magnetar Capital Partners LP - Form 8.3 - Mediclinic International Plc · Persbericht

19 mei 2023 · Magnetar Capital Partners LP - Form 8.3 - Mediclinic International plc · Persbericht

18 mei 2023 · Magnetar Capital Partners LP - Form 8.3 - Mediclinic International plc · Persbericht

17 mei 2023 · Magnetar Capital Partners LP - Form 8.3 - Mediclinic International plc · Persbericht

16 mei 2023 · Magnetar Capital Partners LP - Form 8.3 - Mediclinic International plc · Persbericht

15 mei 2023 · Magnetar Capital Partners LP - Form 8.3 - Mediclinic International plc · Persbericht

12 mei 2023 · Magnetar Capital Partners LP - Form 8.3 - Mediclinic International Plc · Persbericht

4 mei 2023 · Magnetar Capital Partners LP - Form 8.3 - Mediclinic International plc · Persbericht

3 mei 2023 · Magnetar Capital Partners LP - Form 8.3 - Mediclinic International plc · Persbericht

2 mei 2023 · Magnetar Capital Partners LP - Form 8.3 - Mediclinic International plc · Persbericht

28 april 2023 · Magnetar Capital Partners LP - Form 8.3 - Mediclinic International plc · Persbericht

27 april 2023 · Magnetar Capital Partners LP - Form 8.3 - Mediclinic International plc · Persbericht

27 april 2023 · Ninety One UK Ltd - Form 8.3 - Mediclinic International Plc · Persbericht

26 april 2023 · Magnetar Capital Partners LP - Form 8.3 - Mediclinic International plc · Persbericht

25 april 2023 · Magnetar Capital Partners LP - Form 8.3 - Mediclinic International plc · Persbericht

24 april 2023 · Magnetar Capital Partners LP - Form 8.3 - Mediclinic International plc · Persbericht

Mijn selecties